Wockhardt US unit gets FDA warning notePost published:March 1, 2017Post category:Industry NewsProducts of Wockhardt’s US unit Morton Grove Pharma will be available in that market but new approvals will be withheld until compliance issues are resolved Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostMasterCard eyes 1 million traders on its BharatQR platform Next PostYahoo chief counsel exits after hack probe finds inaction You Might Also Like Video: Advanced Intelligent Machine Safety February 3, 2018 How Predictive Maintenance Fits into Industry 4.0 October 7, 2017 Make in India: Govt may waive bank guarantees for mobile component imports April 14, 2017